APA (7th ed.) Citation

JG, R., JT, R., NL, M., KPC, K., SW, T., & EL, T. (2025). Safety and cognitive pharmacodynamics following dose escalations with 3-methylmethcathinone (3-MMC): A first in human, designer drug study. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 50(7), 1084. https://doi.org/10.1038/s41386-024-02042-7

Chicago Style (17th ed.) Citation

JG, Ramaekers, Reckweg JT, Mason NL, Kuypers KPC, Toennes SW, and Theunissen EL. "Safety and Cognitive Pharmacodynamics Following Dose Escalations with 3-methylmethcathinone (3-MMC): A First in Human, Designer Drug Study." Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology 50, no. 7 (2025): 1084. https://doi.org/10.1038/s41386-024-02042-7.

MLA (9th ed.) Citation

JG, Ramaekers, et al. "Safety and Cognitive Pharmacodynamics Following Dose Escalations with 3-methylmethcathinone (3-MMC): A First in Human, Designer Drug Study." Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology, vol. 50, no. 7, 2025, p. 1084, https://doi.org/10.1038/s41386-024-02042-7.